ArticleThe oncologist2022

Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma.

Philip C Mack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.